Phase
Condition
Multiple Myeloma
Cancer/tumors
Leukemia
Treatment
N/AClinical Study ID
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Adult patient (≥18 years) with multiple myeloma who will receive at least one dose ofteclistamab (first dose of the step-up dose)
Exclusion
Exclusion Criteria:
- Patients alive at the start of the study who did not receive study information or whoobjected to the collection of data
- Patients who received teclistamab as part of an interventional clinical trial
- Patients who are initiating teclistamab as part of a current interventional clinicaltrial
Study Design
Connect with a study center
CH d'ANNECY
Annecy,
FranceSite Not Available
Hopital de la cote Basque
Bayonne,
FranceActive - Recruiting
CHU Bordeaux
Bordeaux, 31400
FranceSite Not Available
CHU CAEN
Caen,
FranceSite Not Available
Chu Dijon
Dijon,
FranceSite Not Available
CH Dunkerque
Dunkerque,
FranceSite Not Available
CHU de Lille
Lille,
FranceSite Not Available
CHU de Lyon
Lyon,
FranceSite Not Available
Institut Paoli Calmette
Marseille,
FranceSite Not Available
CH de METZ
Metz,
FranceSite Not Available
Chu de Nantes
Nantes,
FranceSite Not Available
CHU de Nice
Nice,
FranceSite Not Available
Hopital Necker
Paris,
FranceSite Not Available
Hopital saint louis
Paris,
FranceSite Not Available
CH Perpignan
Perpignan,
FranceSite Not Available
Hopital Novo
Pontoise,
FranceSite Not Available
Chu de Rennes
Rennes,
FranceSite Not Available
CHU Toulouse
Toulouse,
FranceSite Not Available
CHU de Tours
Tours,
FranceSite Not Available
CH Bretagne Atlantique
Vannes,
FranceSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.